Heart rhythm safety study of an experimental injection in healthy adults
Part of Hormones & metabolism clinical trials.
This study checks if a new experimental injection, Zovaglutide, affects the heart's electrical activity (QT interval) in healthy adults. It helps ensure the medicine is safe before it is tested in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You weigh more than 60 kg if male, or more than 55 kg if female.
- Your body mass index (BMI) is between 24 and 35.
- You have no history of heart rhythm problems, long QT syndrome, or sudden cardiac death in your family.
- You have not had pancreatitis, medullary thyroid cancer, or certain other conditions.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new diabetes medicine called ZT002 works in the body and whether it interacts safely with other common medications. Researchers will monitor healthy volunteers who are overweight to understand the medicine's safety and effectiveness.
This study tests an investigational drug called Zovaglutide (ZT002) in people with different levels of kidney function, from normal to severely impaired. The goal is to see how the drug is processed by the body and how safe it is for people with kidney problems.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This study tests an investigational injection (JMT206) in people with obesity. The goal is to see if the medicine is safe and tolerable when given multiple times; it may help with weight management in the future.
This study tests whether switching from an existing GLP-1 weight-loss medication (like semaglutide) to a new medicine called zovaglutide is safe and tolerable for adults with obesity. It may help you maintain or improve weight loss with a potentially different medication option.
Hear when a new Overweight, Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.